These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 21930612
21. Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women. Benaboud S, Hirt D, Launay O, Pannier E, Firtion G, Rey E, Bouazza N, Foissac F, Chappuy H, Urien S, Tréluyer JM. Antimicrob Agents Chemother; 2012 Feb; 56(2):857-62. PubMed ID: 22123690 [Abstract] [Full Text] [Related]
22. Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adults. Baheti G, King JR, Acosta EP, Fletcher CV. AIDS; 2013 Jan 14; 27(2):221-5. PubMed ID: 23032419 [Abstract] [Full Text] [Related]
23. Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence? Adams JL, Sykes C, Menezes P, Prince HM, Patterson KB, Fransen K, Crucitti T, De Baetselier I, Van Damme L, Kashuba AD. J Acquir Immune Defic Syndr; 2013 Mar 01; 62(3):260-6. PubMed ID: 23111578 [Abstract] [Full Text] [Related]
27. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, Anderson PL. AIDS Res Hum Retroviruses; 2013 Feb 01; 29(2):384-90. PubMed ID: 22935078 [Abstract] [Full Text] [Related]
32. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Moss JA, Malone AM, Smith TJ, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Vincent KL, Motamedi M, Friend DR, Clark MR, Baum MM. Antimicrob Agents Chemother; 2012 Feb 01; 56(2):875-82. PubMed ID: 22123689 [Abstract] [Full Text] [Related]
33. Models for predicting effective HIV chemoprevention in women. Nicol MR, Emerson CW, Prince HM, Nelson JA, Fedoriw Y, Sykes C, Geller EJ, Patterson KB, Cohen MS, Kashuba AD. J Acquir Immune Defic Syndr; 2015 Apr 01; 68(4):369-76. PubMed ID: 25501616 [Abstract] [Full Text] [Related]
34. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel. Cohen JA, Brache V, Foster J, Cochon L, Callahan M, Schwartz J. Sex Transm Dis; 2013 Jun 01; 40(6):476-81. PubMed ID: 23677021 [Abstract] [Full Text] [Related]
36. Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings. Moss JA, Baum MM, Malone AM, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Willis RA, Vincent KL, Motamedi M, Smith TJ. AIDS; 2012 Mar 27; 26(6):707-10. PubMed ID: 22210639 [Abstract] [Full Text] [Related]
37. Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study. MacQueen KM, Weaver MA, van Loggerenberg F, Succop S, Majola N, Taylor D, Karim QA, Karim SA. AIDS Behav; 2014 May 27; 18(5):826-32. PubMed ID: 24647763 [Abstract] [Full Text] [Related]